Tcheng, J E <br/><br/>
Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.  [electronic resource] 

 -  American heart journal  Feb 2000 
 - S38-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0002-8703 
<br/><br/><label>Standard No.: </label>10.1067/mhj.2000.103742  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Eptifibatide<br/>Hemorrhage--chemically induced<br/>Humans<br/>Myocardial Ischemia--blood<br/>Peptides--adverse effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Recurrence<br/>Risk Factors<br/>Survival Rate<br/>Thrombocytopenia--chemically induced<br/>Tirofiban<br/>Tyrosine--adverse effects